Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06358573 |
| Title | Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early TNBC. INVINCIBLE-4-SAKK |
| Acronym | INVINCIBLE-4-SAKK |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Swiss Group for Clinical Cancer Research |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | CHE |